The DOI matches its Crossref record; 214 of the 214 references it cites were found in a registry or an index.
Biomimetic Nanotechnology toward Personalized Vaccines
Open accessAbstract
While traditional approaches for disease management in the era of modern medicine have saved countless lives and enhanced patient well‐being, it is clear that there is significant room to improve upon the current status quo. For infectious diseases, the steady rise of antibiotic resistance has resulted in super pathogens that do not respond to most approved drugs. In the field of cancer treatment, the idea of a cure‐all silver bullet has long been abandoned. As a result of the challenges facing current treatment and prevention paradigms in the clinic, there is an increasing push for personalized therapeutics, where plans for medical care are established on a patient‐by‐patient basis. Along these lines, vaccines, both against bacteria and tumors, are a clinical modality that could benefit significantly from personalization. Effective vaccination strategies could help to address many challenging disease conditions, but current vaccines are limited by factors such as a lack of potency and antigenic breadth. Recently, researchers have turned toward the use of biomimetic nanotechnology as a means of addressing these hurdles. Recent progress in the development of biomimetic nanovaccines for antibacterial and anticancer applications is discussed, with an emphasis on their potential for personalized medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–214 of 214
Slow‐Release Formulation of Cowpea Mosaic Virus for In Situ Vaccine Delivery to Treat Ovarian Cancer
Czapar, A. E., Tiu, B. D. B., Veliz, F. A., Pokorski, J. K., & Steinmetz, N. F. (2018) · Advanced Science · doi:10.1002/advs.201700991 · Cited by 71
Toxoid Vaccination against Bacterial Infection Using Cell Membrane-Coated Nanoparticles
Angsantikul, P., Fang, R. H., & Zhang, L. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00692 · Cited by 65
Self-citationSeparating T Cell Targeting Components onto Magnetically Clustered Nanoparticles Boosts Activation
Kosmides, A. K., Necochea, K., Hickey, J. W., & Schneck, J. P. (2018) · Nano Letters · doi:10.1021/acs.nanolett.7b05284 · Cited by 65
Lokhov, P. G., & Balashova, E. E. (2010) · Journal of Cancer · doi:10.7150/jca.1.230 · Cited by 59
Inhibition of Tumor-Induced Myeloid-Derived Suppressor Cell Function by a Nanoparticulated Adjuvant
Fernández, A., Mesa, C., Marigo, I., Dolcetti, L., Clavell, M., Oliver, L., Fernandez, L. E., & Bronte, V. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001465 · Cited by 58
Lovly, C. M., & Carbone, D. P. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.224 · Cited by 54
Lin, J., Chien, C.-Y., Lin, C.-L., Yao, B., Chen, Y., Liu, Y.-H., Fang, Z.-S., Chen, J.-Y., Chen, W.-Y., Lee, N.-N., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09049-5 · Cited by 52
Hanlon, D. J., Aldo, P. B., Devine, L., et al. (2011) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2010.00968.x · Cited by 51
Adjuvant‐Loaded Subcellular Vesicles Derived From Disrupted Cancer Cells for Cancer Vaccination
Cheung, A. S., Koshy, S. T., Stafford, A. G., Bastings, M. M. C., & Mooney, D. J. (2016) · Small · doi:10.1002/smll.201600061 · Cited by 49
Vaccine design: emerging concepts and renewed optimism
Grimm, S. K., & Ackerman, M. E. (2013) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2013.02.015 · Cited by 41
Biomimetic Virulomics for Capture and Identification of Cell-Type Specific Effector Proteins
Lapek, J. D., Fang, R. H., Wei, X., Li, P., Wang, B., Zhang, L., & Gonzalez, D. J. (2017) · ACS Nano · doi:10.1021/acsnano.7b02650 · Cited by 31
Self-citationEngineering biological interactions on the nanoscale
Jiang, Y., Chekuri, S., Fang, R. H., & Zhang, L. (2018) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2018.10.005 · Cited by 29
Self-citationLebel, M., Langlois, M.-P., Daudelin, J., Tarrab, E., Savard, P. E., Leclerc, D., & Lamarre, A. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1601271 · Cited by 25
A vaccine from plant virus proteins
Peruzzi, P. P., & Chiocca, E. A. (2015) · Nature Nanotechnology · doi:10.1038/nnano.2015.306 · Cited by 23
Cited by
Targeting drugs to tumours using cell membrane-coated nanoparticles
Fang, R. H., Gao, W., & Zhang, L. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00699-x · Cited by 980
Self-citationRecent Advances in Hyperthermia Therapy‐Based Synergistic Immunotherapy
Chang, M., Hou, Z., Wang, M., Li, C., & Lin, J. (2021) · Advanced Materials · doi:10.1002/adma.202004788 · Cited by 450
Cell membrane coating integrity affects the internalization mechanism of biomimetic nanoparticles
Liu, L., Bai, X., Martikainen, M.-V., Kårlund, A., Roponen, M., Xu, W., Hu, G., Tasciotti, E., & Lehto, V.-P. (2021) · Nature Communications · doi:10.1038/s41467-021-26052-x · Cited by 440
Platelet membrane-camouflaged magnetic nanoparticles for ferroptosis-enhanced cancer immunotherapy
Jiang, Q., Wang, K., Zhang, X., Ouyang, B., Liu, H., Pang, Z., & Yang, W. (2020) · Small · doi:10.1002/smll.202001704 · Cited by 426
Semiconducting polymer nano-PROTACs for activatable photo-immunometabolic cancer therapy
Zhang, C., Zeng, Z., Cui, D., He, S., Jiang, Y., Li, J., Huang, J., & Pu, K. (2021) · Nature Communications · doi:10.1038/s41467-021-23194-w · Cited by 411
Metadata
- Authors
- Zhou, J., Kroll, A. V., Holay, M., Fang, R. H., & Zhang, L.
- Venue
- Advanced Materials
- Publisher
- Wiley
- Published
- 2019-06-17
- Volume
- 32
- Issue
- 13
- Pages
- e1901255-e1901255
- ISSN
- 0935-9648 (ISSN-L)
- 1521-4095
- OpenAlex
- W2952233665
- Cited by
- 328
- References
- 214
- FWCI
- 12.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.